Stocksigma LogoStocksigma Logo

Molbio Diagnostics Schedules Board Meeting for Q2 FY27 Financial Results

Molbio Diagnostics Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the standalone and consolidated unaudited

Molbio Diagnostics Schedules Board Meeting for Q2 FY27 Financial Results

Molbio Diagnostics Ltd 路 Intimation 路 05 Nov 2026, 5:30 am

Molbio Diagnostics Schedules Board Meeting for Q2 FY27 Financial Results Molbio Diagnostics Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities remains closed from 1st Oct'26 until 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Molbio Diagnostics Ltd

All Molbio Diagnostics Ltd announcements